Amanda A. Honeycutt is director of RTI’s Health Economics Program and conducts research to analyze the net value of public health interventions. Dr. Honeycutt applies economic and disease modeling approaches to analyze cost of illness, intervention program costs, and cost-effectiveness. She is the project director for RTI’s Achieving Public Health Impact through Research contract with the Centers for Disease Control and Prevention (CDC) and for RTI’s Economics of HIV Prevention and Care contract for CDC’s Division of HIV and AIDS Prevention. She has led or currently leads numerous studies for CDC and other clients to analyze the costs, outcomes, or cost-effectiveness of public health programs using primary and secondary data and mathematical modeling of disease processes.
Dr. Honeycutt has recently published papers on findings from an evaluation of Communities Putting Prevention Work, a comparison of methods for cost-of-illness analysis, and a cost-effectiveness analysis comparing alternative clinical interventions for treating urinary incontinence. She has also published papers on the lifetime cost of mental retardation, cerebral palsy, hearing loss, and vision impairment as well as papers on the cost of diabetes and chronic kidney disease. Additionally, she has extensive experience in extracting and analyzing information from large databases, including natality detail files and Census data, and in analyzing survey data, such as Current Population Surveys, the National Health Interview Survey, the Medical Expenditure Panel Survey, and the National Health and Nutrition Examination Survey.